Complex 3D Braided Scaffolds for Tissue Ingrowth and Remodeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing musculoskeletal tissue reconstruction methods, such as autografts, allografts, and synthetic substitutes, face limitations including donor site complications, tissue quality variability, poor integration, and long-term mechanical weakness, with no effective synthetic graft options for anterior cruciate ligament reconstruction.

Innovation Solution

Development of complex three-dimensional braided scaffolds made from biodegradable polymers that mimic the mechanical properties and elasticity of injured tissues, allowing for tissue ingrowth and remodeling, with controlled degradation to support regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If autografts are used for tissue reconstruction, then tissue quality and biological compatibility are improved, but donor site complications and function loss occur

Engineering Contradiction:
Improvetissue qualityVSAvoiddonor site complications
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces an acellular dermal matrix scaffold as an intermediary material that provides structural support and facilitates tissue regeneration without requiring donor site harvesting. This mediator enables tissue reconstruction while avoiding the harmful effects of autograft donor site complications

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The acellular dermal matrix serves as a biological template or copy of native tissue structure that guides regenerating cells to form new tissue. By copying the natural tissue architecture, the scaffold enables reconstruction without needing actual donor tissue, thus avoiding donor site harm

Inventive Principle:
Principle #26Copying

2Object-affected harmful factors

If allografts are used for tissue reconstruction, then donor site complications are avoided, but tissue quality variability and higher failure rates occur

Engineering Contradiction:
Improvedonor site complicationsVSAvoidtissue quality consistency
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent modifies the properties of the acellular dermal matrix through controlled processing parameters (cross-linking degree, porosity, thickness) to achieve consistent mechanical strength and biological performance. This parameter control ensures reliable tissue quality without the variability inherent in allografts from different donors

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The acellular dermal matrix is constructed as a composite material combining structural proteins (collagen, elastin) with controlled porosity and mechanical properties. This composite structure provides consistent and reliable tissue quality that is not dependent on donor variation

Inventive Principle:
Principle #40Composite materials

3Strength

If synthetic substitutes are used for tissue reconstruction, then mechanical strength is improved, but poor integration with surrounding tissue and infection risk occur

Engineering Contradiction:
Improvemechanical strengthVSAvoidtissue integration
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The acellular dermal matrix is designed with controlled porosity (30-70% void space) that allows infiltration of regenerating cells, vascular ingrowth, and tissue integration. This porous structure maintains mechanical strength while enabling biological integration that synthetic materials lack

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The patent optimizes the porosity parameter of the acellular dermal matrix to balance mechanical strength and tissue integration. By controlling pore size (10-100 micrometers) and porosity percentage, the scaffold provides both structural support and pathways for cell migration and vascularization

Inventive Principle:
Principle #35Parameter changes

4Reliability

If complex three-dimensional braided scaffolds are used for tissue regeneration, then tissue integration and regeneration are improved, but manufacturing complexity increases

Engineering Contradiction:
Improvetissue integrationVSAvoidscaffold structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The complex three-dimensional braided scaffold is manufactured by segmenting the process into discrete steps: preparing individual polymer yarns, braiding them into the three-dimensional pattern, and then processing the assembled structure. This segmentation makes the complex structure manufacturable through systematic assembly rather than monolithic fabrication

Inventive Principle:
Principle #1Segmentation

Data Source

PatentEP3432940B1Complex braided scaffolds for improved tissue regeneration
Publication Date: 2025.11.05 BIOREZ INC
  • EP3432940B1 patent drawingFigure 1A~1G
  • EP3432940B1 patent drawingFigure 2A~2B
  • EP3432940B1 patent drawingFigure 2C~2D

AI summary

Implantable medical devices and prosthesis for rapid regeneration and replacement of tissues, and methods of making and using the devices, are described. The medical devices include a complex three-dimensional braided scaffold with a polymer composition and structure tailored to desired degradation profiles and mechanical properties. The composite three-dimensional braided scaffolds are braided from yam bundles of biodegradable and bioresorbable polymeric fibers and/or filaments. Monofilament fibers and/or multifilament fibers can be twisted/plied in different combinations to form multifilament yams, composite multifilament yams, or composite yams. The medical devices are useful as both structural prosthetics taking on the function of the tissue as it regenerates and as in vivo scaffolds for cell attachment and ingrowth.